CBUS
Cibus Global LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$101.83M
P/E Ratio
—
EPS
$-2.78
Beta
1.93
52W High
$4.19
52W Low
$1.09
50-Day MA
$2.72
200-Day MA
$1.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cibus Global LLC
Cibus Global, Ltd., a biotechnology company, develops plant traits for seed industry globally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $3.64M |
| Gross Profit (TTM) | $3.64M |
| EBITDA | $-61.54M |
| Operating Margin | -1273.00% |
| Return on Equity | -221.00% |
| Return on Assets | -12.90% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $0.40 |
| Price-to-Book | 6.87 |
| Price-to-Sales (TTM) | 27.98 |
| EV/Revenue | 47.59 |
| EV/EBITDA | -1.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -12.80% |
| Shares Outstanding | $76.17M |
| Float | $52.22M |
| % Insiders | 23.50% |
| % Institutions | 19.07% |
Historical Volatility
HV 10-Day
184.10%
HV 20-Day
169.56%
HV 30-Day
156.00%
HV 60-Day
153.63%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($14.67 target)
2
Buy1
HoldData last updated: 4/10/2026